News Releases 2000

12-15-2000 MDS Reports Record 2000 Results
12-06-2000 MDS Provides New Genetic Test for Colon and Uterine Cancer
10-05-2000 Canadian technology leader celebrates record growth and success
09-28-2000 Xenogen Corporation Announces Acquisition of DNX Transgenic Sciences (DNX)
09-27-2000 MDS Nordion And NEXUS AG Collaborate On Oncology Information Management
09-27-2000 MDS Inc. Announces The Formation Of MDS Pharma Services Third Largest CRO In The World
09-21-2000 MDS Inc. Closes $198 Million Equity Offering
09-14-2000 MDS Inc. Announces Cash Dividend and Stock Dividend
09-14-2000 MDS Reports Third Quarter Earnings
09-06-2000 MDS Announces $153 Million Offering
08-28-2000 First MDS Nordion treatment using IMRT helps cancer patient
08-17-2000 MDS Nordion and Canada's National Research Council Share Technology
07-21-2000 MDS Nordion Supports FDA Ruling to Fight Salmonella in Eggs
06-19-2000 MDS Inc. Normal Course Issuer Bid
06-15-2000 MDS Reports Second Quarter Earnings
06-08-2000 MDS Invests US$15 Million Strategic Investment in INPHACT, a Leading e-Imaging Company
06-01-2000 MDS Capital Corp. Participates In Forming eHealthPark
05-01-2000 MDS Pharma Services Unveils State-of-the-Art Laboratory
04-25-2000 MDS Rings Opening Bell at NYSE
04-07-2000 MDS's Acquisition of Phoenix Completed and Sector Leader Named
04-07-2000 Phoenix Shareholders Accept MDS Offer to Purchase MDS Lists on NYSE
03-31-2000 MDS / Phoenix Acquisition Receives CCB No-Action Letter
03-27-2000 MDS Extends Offer to Phoenix Shareholders
03-23-2000 MDS Inc. to List on NYSE
03-16-2000 Paladin and MDS Announce Availability of NMP22(R) Test for Bladder Cancer in MDS Labs
03-13-2000 Circular Notification - MDS Offer to Phoenix Shareholders
03-09-2000 MDS Brings World-Renowned Genetic Test To Canadian Women
03-09-2000 MDS Acquires INH Technologies Inc.
03-06-2000 MDS Announces Stock Symbol Change
03-03-2000 MDS Inc. Shareholders Approve Share Restructuring
03-02-2000 MDS Reports Strong First Quarter
02-25-2000 Physicians And Patients Collaborate On New Diagnostic Tests
02-24-2000 MDS Inc. Offers to Purchase Phoenix International Life Sciences Inc.